Ibrushil 140mg Capsule
Marketer
Shilpa Medicare Ltd
Salt Composition
Ibrutinib (140mg)
Overview Ibrushil 140mg Capsule
Ibrutinib 140mg capsules are indicated for managing mantle cell lymphoma and a type of blood cancer known as chronic lymphocytic leukemia (CLL). This medication is also prescribed for CLL patients who have undergone at least one prior treatment regimen. Dosage is determined by a physician and treatment length depends on individual patient response. Regular blood tests to monitor blood cell counts are typically conducted during therapy. A reduction in blood cell count, potentially increasing infection risk, is a known side effect. Headache, diarrhea, and nausea are also possible adverse reactions.
Primary Ingredients of Ibrushil 140mg Capsule
No information provided. Please provide the text you wish me to rephrase.
Uses of Ibrushil 140mg Capsule
Mantle cell lymphoma and chronic lymphocytic leukemia are types of blood cancer.
Major Benefits of Ibrushil 140mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Ibrushil 140mg Capsules. These capsules can be taken with or without food, however, consistent timing is recommended.
Common Side effects of Ibrushil 140mg Capsule:
- Headache
- Fever
- Diarrhea
- Stomatitis (Inflammation of the mouth)
- Nausea
- Low blood platelets
- Decreased white blood cell count (neutrophils)
- Fatigue
- Musculoskeletal (bone, muscle or joint) pain
- Rash
- Anemia (low number of red blood cells)
- Bruising
- Muscle spasm
- Hemorrhage
- Pneumonia
- Cough
- Dry eye
- High blood pressure
- Weight loss
- Urinary tract infection
- Peripheral edema
- Subdural hematoma
- Second primary malignancies
How to use Ibrushil 140mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Ibrushil 140mg Capsules. These capsules can be administered with or without food, though consistent timing is recommended.
How Ibrushil 140mg Capsule works:
Ibrushil 140mg capsules target Bruton's tyrosine kinase, halting the activity of a faulty protein that drives cancer cell proliferation. This action inhibits or reduces the growth of cancerous tissues.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Ibrushil 140mg Capsule with alcohol is undefined regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Ibrushil 140mg Capsules is contraindicated during pregnancy due to established risks to the fetus. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCAUTION
The use of Ibrushil 140mg Capsules while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding throughout their treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Ibrushil 140mg Capsules.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Ibrushil 140mg Capsules. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Ibrushil 140mg capsules cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Ibrushil 140mg Capsule :
NA
Facts to Know About Ibrushil 140mg Capsule
| Label | Value |
|---|---|
| Chemical Type | Diphenyl ether derivative |
| Developing Habits | No. |
| Type of Therapy | Cancer Treatments |
| Active Class | BTK inhibitors |
3,018 People bought this recently